Northeast Financial Consultants’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,039
Closed -$845K 294
2023
Q1
$845K Hold
3,039
0.05% 153
2022
Q4
$842K Sell
3,039
-241
-7% -$66.7K 0.06% 151
2022
Q3
$876K Hold
3,280
0.06% 147
2022
Q2
$669K Sell
3,280
-559
-15% -$114K 0.05% 164
2022
Q1
$808K Hold
3,839
0.05% 176
2021
Q4
$921K Hold
3,839
0.06% 160
2021
Q3
$1.09M Hold
3,839
0.07% 151
2021
Q2
$1.33M Sell
3,839
-45
-1% -$15.6K 0.09% 133
2021
Q1
$1.09M Hold
3,884
0.08% 139
2020
Q4
$951K Hold
3,884
0.08% 141
2020
Q3
$1.1M Hold
3,884
0.1% 118
2020
Q2
$1.04M Hold
3,884
0.1% 117
2020
Q1
$1.23M Hold
3,884
0.14% 93
2019
Q4
$1.15M Buy
3,884
+809
+26% +$240K 0.1% 121
2019
Q3
$716K Sell
3,075
-46
-1% -$10.7K 0.07% 150
2019
Q2
$730K Sell
3,121
-133
-4% -$31.1K 0.07% 153
2019
Q1
$769K Buy
+3,254
New +$769K 0.09% 142
2018
Q3
Sell
-2,743
Closed -$796K 153
2018
Q2
$796K Hold
2,743
0.25% 62
2018
Q1
$751K Hold
2,743
0.25% 65
2017
Q4
$873K Hold
2,743
0.29% 52
2017
Q3
$859K Hold
2,743
0.31% 52
2017
Q2
$744K Hold
2,743
0.29% 62
2017
Q1
$750K Sell
2,743
-24
-0.9% -$6.56K 0.31% 58
2016
Q4
$785K Buy
2,767
+224
+9% +$63.5K 0.35% 53
2016
Q3
$796K Hold
2,543
0.34% 57
2016
Q2
$615K Sell
2,543
-1,197
-32% -$289K 0.27% 64
2016
Q1
$973K Buy
3,740
+21
+0.6% +$5.46K 0.51% 38
2015
Q4
$1.14M Hold
3,719
0.59% 38
2015
Q3
$1.09M Buy
3,719
+563
+18% +$164K 0.55% 36
2015
Q2
$1.28M Hold
3,156
0.57% 38
2015
Q1
$1.33M Sell
3,156
-705
-18% -$298K 0.61% 36
2014
Q4
$1.31M Hold
3,861
0.69% 33
2014
Q3
$1.28M Hold
3,861
0.7% 30
2014
Q2
$1.22M Hold
3,861
0.69% 31
2014
Q1
$1.18M Buy
+3,861
New +$1.18M 0.7% 27